SIX Swiss Exchange · Healthcare
Invest in Medartis stock from India
Indian and foreign residents can buy Medartis (MED) shares directly through Paasa.
By Paasa · Updated
Medartis at a glance
- Price
- CHF 84.00-CHF 0.70 (0.83%)
- Market cap
- CHF 1.05B
- Day range
- CHF 83.00 – CHF 85.90
- P/E
- 70.00
- Dividend yield
- None
- Volume
- 4.37K
- 1 month
- -8.70%
- 6 months
- +9.09%
- YTD
- -4.76%
- 1 year
- -3.45%
- 5 years
- -22.79%
Medartis statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CHF 269.3M | CHF 224.8M | CHF 212.0M | CHF 182.8M | CHF 159.9M |
| Gross profit | CHF 204.3M | CHF 178.7M | CHF 167.6M | CHF 135.4M | CHF 121.6M |
| Operating income | CHF 1.9M | CHF 7.9M | CHF 9.1M | −CHF 1.9M | CHF 11.0M |
| Net income | CHF 8.3M | CHF 3.5M | CHF 619.0K | −CHF 5.8M | CHF 6.8M |
| Earnings per share | CHF 0.67 | CHF 0.28 | CHF 0.05 | −CHF 0.49 | CHF 0.58 |
| EBITDA | CHF 45.7M | CHF 30.2M | CHF 24.7M | CHF 15.6M | CHF 26.1M |
| Total assets | CHF 559.9M | CHF 460.0M | CHF 349.5M | CHF 327.9M | CHF 298.2M |
| Total debt | CHF 157.7M | CHF 121.2M | CHF 27.4M | CHF 28.0M | CHF 24.1M |
| Cash and short-term investments | CHF 33.0M | CHF 138.7M | CHF 25.2M | CHF 20.6M | CHF 82.6M |
| Shareholders' equity | CHF 275.9M | CHF 269.6M | CHF 255.0M | CHF 237.8M | CHF 224.0M |
| Operating cash flow | CHF 34.8M | CHF 28.2M | CHF 20.0M | −CHF 3.9M | CHF 21.0M |
| Free cash flow | CHF 9.3M | CHF 21.0M | CHF 5.0M | −CHF 22.7M | CHF 10.6M |
| Capital expenditure | −CHF 25.5M | −CHF 7.2M | −CHF 14.9M | −CHF 18.8M | −CHF 10.4M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CHF; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| SKAN | SKAN.SW | CHF 70.70 | CHF 1.59B |
| PolyPeptide | PPGN.SW | CHF 44.10 | CHF 1.46B |
| Aevis Victoria | AEVS.SW | CHF 15.75 | CHF 1.33B |
| Idorsia | IDIA.SW | CHF 4.65 | CHF 1.22B |
| Cosmo Pharmaceuticals | COPN.SW | CHF 58.70 | CHF 1.01B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Medartis from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search MED and buy
Find Medartis by name or by its ticker, MED, and place your order.
Why invest in Medartis from India
What Medartis does
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs. Medartis operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Medartis stock from India?
Yes. Indian residents and NRIs can buy Medartis (MED) shares directly through Paasa. Medartis is listed on the SIX Swiss Exchange, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Medartis shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.